Information is power. Our mission at Portside is to seek out and to provide information that empowers you -- that empowers the left. Every day we search hundreds of sources to connect you with the most interesting, striking and useful material. Just once a year we appeal to you to contribute to make it possible to continue this work. Please help.
What if a team of people in recovery from drug addiction were enlisted to teach the pharmaceutical executives what it really means to take responsibility?
...now is the time for bold long-term solutions that can help secure the future health and well being of our communities. Public pharmaceuticals can play an important role in constructing that future we so desperately need.
Our strategy is simple: mobilize millions of Americans across this country to stand up and demand that politicians choose a side, the American people or the pharmaceutical corporations.
Insulin is a 100-year-old drug whose wholesale price has tripled in ten years. The reasons why explain everything wrong with America’s broken prescription drug market.
The lawsuit claims Purdue paid members of the Sackler family more than $4 billion between 2008 and 2016.
An inefficiency gap is boosting costs — and profits
Eschewing policies to lower costs here, the president tells drug companies to raise their prices abroad. (We’re not making this up.)
The myth is that pharmaceutical industry profits come from producing and selling the many therapeutic advances that industry research has generated, but the reality is far different.
A sweeping study of drug R&D funding shows the public pays for the crucial foundations of medical breakthroughs. So why not let the public have access to them?
The Medicare Drug Price Negotiation Act of 2017 would finally allow the government to negotiate directly with drug companies to lower prices for Medicare beneficiaries, much like the VA and Medicaid do today.
Spread the word